Pfizer | Patient Daily

Pfizer

Bree Gonzales | Mar 23, 2022

Pfizer and BioNTech request EUA for additional COVID-19 booster shots for people 65 and older

Bree Gonzales | Feb 2, 2022

Molnupiravir is now the last choice for COVID-19: 'The Merck product is only 30% effective'

Bree Gonzales | Aug 28, 2021

Pfizer’s is the first FDA-approved coronavirus vaccine, and now it has a name: Comirnaty

Harmony Valdoz | Aug 28, 2018

Pharmaceutical industry group backs proposal to share drug savings with Medicare beneficiaries

Press release submission | Apr 28, 2018

PFIZER: MYLOTARG™ Approved In The EU For The Treatment Of Previously Untreated, De Novo, CD33-positive Acute Myeloid Leukemia In Combination With Chemotherapy

Press release submission | Apr 28, 2018

PFIZER: Pfizer Provides Update on Proposed Trastuzumab Biosimilar

Carol Ostrow | Jan 7, 2018

Merck, Pfizer Type 2 diabetes treatments gain FDA approval

Carol Ostrow | Dec 26, 2017

Bristol-Myers Squibb, Pfizer, others aim to raise awareness of stroke risk in atrial fibrillation patients

Trending

Patient Daily | Sep 17, 2025

Patients Come First spokesperson: Drug ads 'are putting lives at risk by encouraging people to abandon essential treatments'

Patient Daily | Sep 17, 2025

PhRMA’s Senior Director on 340B: 'State and federal investigations have shown 340B is often exploited for profit'

Patient Daily | Sep 19, 2025

ENT specialist on ongoing chronic sinus cases: ‘Some of it could be incomplete surgery’

+ Pharmaceuticals

Patient Daily | Sep 23, 2025

Wall Street Journal editorial board alleges hospitals misuse 340B program